Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral …
Q Yuan, X Zhang, W Wei, J Zhao, Y Wu, S Zhao… - Pharmacological …, 2022 - Elsevier
Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus
and no effective therapy is approved. Here, lycorine, a natural alkaloid, was identified as a …
and no effective therapy is approved. Here, lycorine, a natural alkaloid, was identified as a …
Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral …
Q Yuan, X Zhang, W Wei, J Zhao… - Pharmacological …, 2022 - pubmed.ncbi.nlm.nih.gov
Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus
and no effective therapy is approved. Here, lycorine, a natural alkaloid, was identified as a …
and no effective therapy is approved. Here, lycorine, a natural alkaloid, was identified as a …
Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral …
Q Yuan, X Zhang, W Wei, J Zhao, Y Wu… - Pharmacological …, 2021 - europepmc.org
Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus
and no effective therapy is approved. Here, lycorine, a natural alkaloid, was identified as a …
and no effective therapy is approved. Here, lycorine, a natural alkaloid, was identified as a …